Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast Cancer. | Geburtshilfe Frauenheilkd | 2023 | 37916184 | PubTator, text mining | PubMed |
| Overcoming the challenges of drug development in platinum-resistant ovarian cancer. | Front Oncol | 2023 | 37916177 | PubTator, text mining | PubMed |
| Utility of the Growth Differentiation Factor-15 in the Differential Diagnosis of Follicular-Patterned Lesions of the Thyroid on Cytopathologic and Histopathologic Samples. | Cureus | 2023 | 37905271 | PubTator, text mining | PubMed |
| Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges. | Genes (Basel) | 2023 | 37895255 | PubTator, text mining | PubMed |
| Unveiling the Immune Microenvironment's Role in Breast Cancer: A Glimpse into Promising Frontiers. | Int J Mol Sci | 2023 | 37895012 | PubTator, text mining | PubMed |
| Colorectal Cancer Is Borrowing Blueprints from Intestinal Ontogenesis. | Cancers (Basel) | 2023 | 37894295 | PubTator, text mining | PubMed |
| Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression. | Cancer Cell | 2023 | 37890493 | PubTator, text mining | PubMed |
| The Impact of Trophoblast Cell-Surface Antigen 2 Expression on the Survival of Patients with Gastrointestinal Tumors: A Systematic Review. | J Pers Med | 2023 | 37888056 | PubTator, text mining | PubMed |
| Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories. | J Pers Med | 2023 | 37888038 | PubTator, text mining | PubMed |
| Breast cancer organoids and their applications for precision cancer immunotherapy. | World J Surg Oncol | 2023 | 37884976 | PubTator, text mining | PubMed |
| NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology. | NPJ Precis Oncol | 2023 | 37884744 | PubTator, text mining | PubMed |
| Antibody drug conjugates: hitting the mark in pancreatic cancer? | J Exp Clin Cancer Res | 2023 | 37880707 | PubTator, text mining | PubMed |
Elucidating Novel Targets for Ovarian Cancer Antibody-Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity. | Antibodies (Basel) | 2023 | 37873862 | PubTator, text mining | PubMed |
| Novel Therapeutic Options for Small Cell Lung Cancer. | Curr Oncol Rep | 2023 | 37870696 | PubTator, text mining | PubMed |
| Assessing real-world safety concerns of Sacituzumab govitecan: a disproportionality analysis using spontaneous reports in the FDA adverse event reporting system. | Front Oncol | 2023 | 37869095 | PubTator, text mining | PubMed |
| Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts. | Curr Oncol Rep | 2023 | 37855848 | PubTator, text mining | PubMed |
| Genome-wide association study for growth traits in Blanco Orejinegro and Romosinuano cattle. | Trop Anim Health Prod | 2023 | 37848724 | PubTator, text mining | PubMed |
| Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development. | Nat Commun | 2023 | 37845228 | PubTator, text mining | PubMed |
| Current and Emerging Strategies to Treat Urothelial Carcinoma. | Cancers (Basel) | 2023 | 37835580 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of Patient Tumor Single-Cell Transcriptomes Identifies Promising Selective and Safe Chimeric Antigen Receptor Targets in Head and Neck Cancer. | Cancers (Basel) | 2023 | 37835579 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=47